Amy Mcbride Wendell Buys 13,333 Shares of AxoGen Inc. (AXGN) Stock
AxoGen Inc. (NASDAQ:AXGN) Director Amy Mcbride Wendell bought 13,333 shares of the company’s stock in a transaction on Friday, October 7th. The stock was purchased at an average cost of $7.50 per share, for a total transaction of $99,997.50. Following the completion of the transaction, the director now owns 13,333 shares in the company, valued at $99,997.50. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink.
Shares of AxoGen Inc. (NASDAQ:AXGN) remained flat at $8.72 on Friday. 292,026 shares of the stock traded hands. The firm’s 50 day moving average is $8.74 and its 200 day moving average is $6.97. AxoGen Inc. has a 1-year low of $4.08 and a 1-year high of $9.88. The company’s market cap is $262.75 million.
AxoGen (NASDAQ:AXGN) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.09) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.03. AxoGen had a negative return on equity of 193.60% and a negative net margin of 37.90%. Equities analysts forecast that AxoGen Inc. will post ($0.40) earnings per share for the current year.
Separately, Wedbush reaffirmed an “outperform” rating and issued a $10.00 target price (up from $9.00) on shares of AxoGen in a research report on Thursday, August 4th.
Several large investors have recently made changes to their positions in the company. UBS Group AG raised its position in AxoGen by 991.7% in the first quarter. UBS Group AG now owns 97,946 shares of the company’s stock valued at $525,000 after buying an additional 88,974 shares in the last quarter. Bank of New York Mellon Corp raised its position in AxoGen by 196.8% in the second quarter. Bank of New York Mellon Corp now owns 80,580 shares of the company’s stock valued at $555,000 after buying an additional 53,427 shares in the last quarter. California State Teachers Retirement System acquired a new position in AxoGen during the second quarter valued at $348,000. Nationwide Fund Advisors acquired a new position in AxoGen during the second quarter valued at $105,000. Finally, Vanguard Group Inc. raised its position in AxoGen by 61.5% in the second quarter. Vanguard Group Inc. now owns 775,448 shares of the company’s stock valued at $5,335,000 after buying an additional 295,294 shares in the last quarter. 57.99% of the stock is owned by institutional investors and hedge funds.
Receive News & Stock Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related stocks with our FREE daily email newsletter.